Amedisys Inc

Amedisys Inc(AMED)股票分析

$100.990

+0.010 (+0.01%)收盘时

Loading chart…
最高
101.020
开盘
101.020
成交量加权均价
100.98
成交量
1.06M
市值
3.04B
最低
100.930
成交额
107.04M
企业价值/息税折旧摊销前利润(TTM)
12.17

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.

分析师评级(11)

上行空间 +2.24%
持有
5 买入
6 持有
0 卖出
当前: 100.99
最低
101.00
平均
103.25
最高
110.00

RBC Capital

2025-04-16

目标价

$100

买入

Stephens & Co.

2025-03-04

目标价

$101

持有

Stephens & Co.

2025-02-12

目标价

$101

持有

Deutsche Bank

2024-07-31

目标价

$101

持有

Cantor Fitzgerald

2024-07-25

目标价

$101

持有

估值指标

Amedisys Inc(AMED)当前预期市盈率为 18.61,5 年平均预期市盈率为 21.51。

预期市盈率

合理
5 年均值 P/E
21.51
当前P/E
18.61
高估
25.29
低估
17.73

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.67
当前EV/EBITDA
12.17
高估
17.32
低估
12.02

预期市销率

合理
5 年均值 P/S
1.43
当前P/S
1.21
高估
1.77
低估
1.09

Alphio AI 对 AMED 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%AMED

$104.36

情景价格

基

基准

基准 · 50%AMED

$83.35

情景价格

悲

悲观

悲观 · 25%AMED

$78.33

情景价格

AMED 常见问题 —— 由 Alphio AI 解答

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

11 analysts cover AMED: 5 rate it Buy, 6 Hold and 0 Sell. The average price target is 103.25.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易